Similar articles

• Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial.

  Solomon SD, Janardhanan R, Verma A, Bourgoun M, Daley WL, Purkayastha D, Lacourcière Y, Hippler SE, Fields H, Naqvi TZ, Mulvagh SL, Arnold JM, Thomas JD, Zile MR, Aurigemma GP; Valsartan In Diastolic Dysfunction (VALIDD) Investigators. Solomon SD, et al. Lancet. 2007 Jun 23;369(9579):2079-87. doi: 10.1016/S0140-6736(07)60980-5. Lancet. 2007. PMID: 17586303 Clinical Trial.
• [VALUE].

  Okura T, Higaki J. Okura T, et al. Nihon Rinsho. 2006 Aug;64 Suppl 6:419-24. Nihon Rinsho. 2006. PMID: 16981573 Review. Japanese. No abstract available.
• Valsartan and the renin-angiotensin-aldosterone system: blood pressure control and beyond.

  Dahlöf B. Dahlöf B. J Renin Angiotensin Aldosterone Syst. 2000 Jun;1(2 Suppl):S14-6. doi: 10.3317/jraas.2000.047. J Renin Angiotensin Aldosterone Syst. 2000. PMID: 17199213 Review.
• Cardiac angiotensin is upregulated in the hearts of unstable angina patients.

  Luft FC. Luft FC. Circ Res. 2004 Jun 25;94(12):1530-2. doi: 10.1161/01.RES.0000134762.66794.16. Circ Res. 2004. PMID: 15217917 No abstract available.
• [Risk oriented therapy of hypertension. Lowering blood pressure and risk].

  [No authors listed] [No authors listed] MMW Fortschr Med. 2007 Nov 15;149(46):53. MMW Fortschr Med. 2007. PMID: 18069196 German. No abstract available.